CJC-1295 (5mg) + Ipamorelin (10mg) – 15mg Peptide Blend

Category Growth Hormone & Release

Description CJC-1295 and Ipamorelin are research peptides commonly studied for their roles in growth hormone (GH) regulationand physiological recovery. CJC-1295 is a GH-releasing hormone (GHRH) analog that stimulates the growth hormone-releasing hormone receptor (GHRHr), leading to the natural release of GH in research models. Studies suggest it may play a role in enhancing growth hormone pulsatility, which is essential for cellular regeneration and metabolic processes.Ipamorelin, a highly selective growth hormone secretagogue (GHS), is a potent agonist of the ghrelin/GH secretagogue receptor (GHS-R). Research indicates it may contribute to bone health, muscle recovery, and metabolic function while also stimulating insulin release and supporting gastrointestinal motility.When researched together, CJC-1295 and Ipamorelin have demonstrated synergistic effects, potentially leading to enhanced GH release while minimizing unwanted fluctuations in hormone levels. This combination is widely studied for its potential applications in muscle development, recovery, and overall endocrine regulation. For research purposes only.